STOCK TITAN

Planned sale of 1,230 SDGR shares disclosed in Rule 144 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of SDGR common stock filed a Rule 144 notice to sell 1,230 shares through Merrill Lynch Wealth Management on the NASDAQ, with an aggregate market value of 16518.9. The issuer reported 64,500,510 shares outstanding.

The securities to be sold were originally acquired as a stock bonus from the issuer on 02/09/2023, when the holder received 2,636 common shares as consideration. The planned sale date is approximately 02/09/2026, and the filer represents they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SDGR Rule 144 filing disclose?

The filing discloses a planned sale of 1,230 SDGR common shares under Rule 144. The shares will be sold through Merrill Lynch on NASDAQ, with an aggregate market value of 16518.9, providing notice of a potential secondary market transaction.

How many SDGR shares are planned for sale in this Rule 144 notice?

The notice covers a planned sale of 1,230 SDGR common shares. These shares are to be sold on NASDAQ through Merrill Lynch Wealth Management, with the filing indicating an aggregate market value of 16518.9 for the proposed transaction under Rule 144.

When and how were the SDGR shares being sold acquired?

The SDGR shares were acquired on 02/09/2023 as a stock bonus from the issuer. On that date, the holder received 2,636 common shares as compensation, and a portion of those shares is now planned for resale under Rule 144 procedures.

What is the aggregate market value of the SDGR shares in this Form 144?

The aggregate market value of the 1,230 SDGR common shares covered by this notice is 16518.9. This figure reflects the total market value of the shares intended for sale through Merrill Lynch Wealth Management on NASDAQ under Rule 144.

How many SDGR shares are outstanding according to the filing?

The filing states that 64,500,510 SDGR common shares are outstanding. This figure provides context for the planned sale of 1,230 shares, showing the proposed transaction is small relative to the issuer’s total shares in circulation.

What is the planned timing for the SDGR Rule 144 share sale?

The approximate date of sale for the 1,230 SDGR common shares is 02/09/2026. The transaction is expected to occur on NASDAQ through Merrill Lynch Wealth Management, consistent with standard Rule 144 resale procedures disclosed in the notice.
Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Latest SEC Filings

SDGR Stock Data

1.00B
62.80M
2.62%
108.07%
12.7%
Health Information Services
Pharmaceutical Preparations
Link
United States
NEW YORK